About Us
Our Company
Leadership
Compliance
Contact
Medical Education Grants
Our
Medicines
YCANTH
Product
Candidates
Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications
Investors &
Media
Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection
Careers
Menu
About Us
Our Company
Leadership
Compliance
Contact
Medical Education Grants
Our
Medicines
YCANTH
Product
Candidates
Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications
Investors &
Media
Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection
Careers
For information about YCANTHâ„¢ or to request a representative, visit YCANTHPro.com
SEC Filing Group:
Quarterly Filings
0000950170-22-022647
0000950170-22-016660
0000950170-22-008242
10-q0000950170-21-004249
0001564590-21-042894
2-0001564590-21-025318
0001564590-20-036455
0001564590-20-036455
164-10-Q -20200507
142-10-Q -20191106
←
older